Home » Topics » BioWorld Science

BioWorld Science
RSS

Animal and human results presented on Aronex's lead anti-HIV integrase inhibitor

Sep. 27, 1996

Ciba characterizes another novel HIV protease inhibitor

Sep. 27, 1996

U.K. introduction for lamivudine

Sep. 27, 1996

Novel class of HIV protease inhibitors with improved activity

Sep. 27, 1996

Anti-HIV research continues at Boehringer Ingelheim

Sep. 27, 1996

Anti-HIV bicyclic phosphoramides from DuPont Merck

Sep. 27, 1996

New antiinfluenza virus agent reported by Gilead Sciences

Sep. 27, 1996

Topical Reticulose reported to be effective against HPV

Sep. 27, 1996

Efficacy and safety of antisense compound for CMV retinitis confirmed

Sep. 27, 1996

Lilly's newest antipicornavirus agents

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026